Bharat Biotech has teamed up with ViroVax to use the US scientific research firm’s adjuvant for boosting the immune response and providing long-lasting immunity to its novel vaccine candidate Covaxin, which has entered phase-2 human trials.from Industry-Economic Times
Read The Rest:economictimes...
